List of works - Jan Lycke

A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis

scientific article published on 12 January 2011

A diagnosis not to miss: pheochromocytoma during pregnancy

scientific article

A nationwide survey of the prevalence of multiple sclerosis in immigrant populations of Sweden ⬇️

scientific article published on December 29, 2011

A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS.

scientific article published in January 2002

Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis

scientific article published in May 1997

Acyclovir concentrations in serum and cerebrospinal fluid at steady state

scientific article published on 01 December 1989

Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir.

scientific article

Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study

scientific article published in March 1996

Age-dependent effects on the treatment response of natalizumab in MS patients

scientific article published on 27 May 2014

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

scientific article published on 29 September 2013

Asymptomatic visual loss in multiple sclerosis

scientific article published in December 2001

Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.

scientific article

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.

scientific article

CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatment

scientific article published on 13 February 2014

Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis

scientific article published on 15 October 2012

Cerebrospinal fluid growth-associated protein 43 in multiple sclerosis

scientific article published on 21 November 2019

Clinical case reviews in multiple sclerosis spasticity: experiences from around Europe.

scientific article published on December 2013

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.

scientific article

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

scientific article published on 17 June 2019

Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies

scientific article published on 25 November 2019

First reported case of diabetes mellitus type 1 as a possible secondary autoimmune disease following alemtuzumab treatment in MS

scientific article published on 01 August 2014

Glial fibrillary acidic protein in CSF of multiple sclerosis patients: relation to neurological deficit

scientific article published on 01 November 1995

Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis

scientific article published in January 2011

High nationwide incidence of multiple sclerosis in Sweden

scientific article published in 2014

High nationwide prevalence of multiple sclerosis in Sweden

scientific article published in April 2011

High risk of MS in Iranian immigrants in Gothenburg, Sweden.

scientific article published on 29 July 2010

Human spumaretrovirus antibody reactivity in multiple sclerosis

scientific article published on 01 February 1994

IL-10 and IFN-gamma in Guillain-Barré syndrome. Network Members of the Swedish Epidemiological Study Group

scientific article published on 01 January 2001

IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: implications for their possible immunopathogenic roles

scientific article published on 19 April 2006

Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides

scientific article published on July 1991

Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis

scientific article published on 23 May 2013

Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden.

scientific article published on September 1990

Inflammation-related plasma and CSF biomarkers for multiple sclerosis

scientific article published on 26 May 2020

Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis

scientific article published on 24 June 2020

Leukocyte myeloperoxidase and pathogenesis of the post-polio syndrome

scientific article published in 2010

Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosis

scientific article published on 01 October 1996

Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosis

scientific article published on 01 July 1996

MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS).

scientific article

Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis

scientific article published on 12 March 2019

Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS

scientific article published on 01 December 2003

Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis.

scientific article published on March 1998

Neuromyelitis optica--important differential diagnosis to MS. Early treatment initiation crucial for the prognosis

scientific article published on December 2010

No evidence for spumavirus or oncovirus infection in relapsing-remitting multiple sclerosis.

scientific article

Peripheral neuropathy associated with monoclonal IgM antibody to glycolipids with a terminal glucuronyl-3-sulfate epitope

scientific article published in June 1993

Possible association of HTLV-I infection and dementia.

scientific article published in September 1993

Regional cerebral blood flow in multiple sclerosis measured by single photon emission tomography with technetium-99m hexamethylpropyleneamine oxime

scientific article published on 01 January 1993

Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF

scientific article

Serum and CSF measles antibody levels increase over time in patients with multiple sclerosis or clinically isolated syndrome

scholarly article by Cecilia Ahlgren et al published June 2012 in Journal of Neuroimmunology

Serum levels of LIGHT in MS

article by Clas Malmeström et al published 4 October 2012 in Multiple Sclerosis Journal

Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone

Soluble interleukin-2 receptor levels in serum of patients with demyelinating polyneuropathy associated with monoclonal gammopathy.

scientific article published on June 1993

Successful epilepsy surgery in a patient with neurosarcoidosis

scientific article published on 30 April 2010

The aciclovir metabolite CMMG is detectable in the CSF of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatment.

scientific article published on 15 March 2006

The effect of live, attenuated measles vaccine and measles infection on measles antibody levels in serum and CSF of patients with multiple sclerosis or clinically isolated syndrome

scientific article

Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs.

scientific article published on November 2012

Use of immunoreactive synthetic HTLV-1 peptides in the search for antibody reactivity in multiple sclerosis.

scientific article published in January 1992

Weaning from mechanical support in a patient with acute heart failure and multiple sclerosis

scientific article published on 01 February 2000

[Changing neurology--from diagnostic to therapeutic discipline]

scientific article published on 01 September 2008

[Pregnancy in multiple sclerosis requires initiated counseling and adapted therapy. Good chance of complications free pregnancy, normal labor and a healthy child]

scientific article published on 01 September 2007

[Representantives of the Swedish Neurological Association: Swedish neurology needs strong resource reinforcement]

scientific article published on 01 September 2008

List of works by Jan Lycke

A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis

A diagnosis not to miss: pheochromocytoma during pregnancy

A nationwide survey of the prevalence of multiple sclerosis in immigrant populations of Sweden ⬇️

A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS.

Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis

Acyclovir concentrations in serum and cerebrospinal fluid at steady state

Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir.

Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study

Age-dependent effects on the treatment response of natalizumab in MS patients

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

Asymptomatic visual loss in multiple sclerosis

Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.

CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatment

Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis

Cerebrospinal fluid growth-associated protein 43 in multiple sclerosis

Clinical case reviews in multiple sclerosis spasticity: experiences from around Europe.

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies

First reported case of diabetes mellitus type 1 as a possible secondary autoimmune disease following alemtuzumab treatment in MS

Glial fibrillary acidic protein in CSF of multiple sclerosis patients: relation to neurological deficit

Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis

High nationwide incidence of multiple sclerosis in Sweden

High nationwide prevalence of multiple sclerosis in Sweden

High risk of MS in Iranian immigrants in Gothenburg, Sweden.

Human spumaretrovirus antibody reactivity in multiple sclerosis

IL-10 and IFN-gamma in Guillain-Barré syndrome. Network Members of the Swedish Epidemiological Study Group

IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: implications for their possible immunopathogenic roles

Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides

Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis

Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden.

Inflammation-related plasma and CSF biomarkers for multiple sclerosis

Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis

Leukocyte myeloperoxidase and pathogenesis of the post-polio syndrome

Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosis

Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosis

MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS).

Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis

Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS

Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis.

Neuromyelitis optica--important differential diagnosis to MS. Early treatment initiation crucial for the prognosis

No evidence for spumavirus or oncovirus infection in relapsing-remitting multiple sclerosis.

Peripheral neuropathy associated with monoclonal IgM antibody to glycolipids with a terminal glucuronyl-3-sulfate epitope

Possible association of HTLV-I infection and dementia.

Regional cerebral blood flow in multiple sclerosis measured by single photon emission tomography with technetium-99m hexamethylpropyleneamine oxime

Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF

Serum and CSF measles antibody levels increase over time in patients with multiple sclerosis or clinically isolated syndrome

Serum levels of LIGHT in MS

Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone

Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone

Soluble interleukin-2 receptor levels in serum of patients with demyelinating polyneuropathy associated with monoclonal gammopathy.

Successful epilepsy surgery in a patient with neurosarcoidosis

The aciclovir metabolite CMMG is detectable in the CSF of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatment.

The effect of live, attenuated measles vaccine and measles infection on measles antibody levels in serum and CSF of patients with multiple sclerosis or clinically isolated syndrome

Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs.

Use of immunoreactive synthetic HTLV-1 peptides in the search for antibody reactivity in multiple sclerosis.

Weaning from mechanical support in a patient with acute heart failure and multiple sclerosis

[Changing neurology--from diagnostic to therapeutic discipline]

[Pregnancy in multiple sclerosis requires initiated counseling and adapted therapy. Good chance of complications free pregnancy, normal labor and a healthy child]

[Representantives of the Swedish Neurological Association: Swedish neurology needs strong resource reinforcement]